Chevy Chase Trust’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
OAM
Chevy Chase Trust's CDNA Position: Q2 2026 in Review
Chevy Chase Trust reduced its CareDx (CDNA) stake by 4.4% in Q2 2026, selling an estimated $1.45M and leaving 1,437,416 shares worth $41M. The position accounts for 0.11% of the portfolio, ranked #155.
Chevy Chase Trust first reported a position in CDNA in Q1 2025 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Chevy Chase Trust held 1,437,416 shares of CareDx worth $41M as of Q2 2026.
- Chevy Chase Trust sold 66,659 CareDx shares in Q2 2026, an estimated $1.45M.
- CareDx made up 0.11% of Chevy Chase Trust's portfolio in Q2 2026, its #155 holding.
- Chevy Chase Trust first reported a position in CareDx in Q1 2025 and has held it in 6 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Chevy Chase Trust's 13F filing for Q2 2026, filed 14 Aug 2026.